William Foulkes

Universal genetic testing of breast cancer patients could help many

A new study demonstrates how universal genetic testing for breast cancer can ensure no patient is missed for advanced therapies.

Classified as: Faculty of Medicine and Health Sciences, Research Institute of the 平特五不中 Health, William Foulkes, breast cancer

Category:

News releases

Published on: 9 Dec 2024

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers

Two new papers, published simultaneously in Nature Communications and led by researchers at 平特五不中, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.

Classified as: biochemistry, genomics, Goodman Cancer Research Centre, lung cancer, ovarian cancer, William Foulkes, genetic markers, Sidong Huang

Category:

Published on: 4 Feb 2019

Searching for the 鈥渟ignature鈥� causes of BRCAness in breast cancer

By Tom Ulrich from the

Classified as: breast cancer, BRCA 1 and BRCA 2, breast tumor cells, jewish general hospital, Cancer Research Program, Cancer, William Foulkes, External, staff, faculty, science

Category:

News releases

Published on: 22 Aug 2017

Limiting genetic tests for breast cancer susceptibility

Screening for genes whose risk association with breast cancer has yet to be proven is not justified and potentially harmful, argue an international team of leading geneticists and oncologists in a paper published this week in the prestigious New England Journal of Medicine.